NCT00099996View on ClinicalTrials.gov

Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2005

Conditions
Heart DiseasesMetabolism, Inborn Errors
Interventions
DRUG

SCH-58235

DRUG

Ezetimibe

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00099996 - Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia | Biotech Hunter | Biotech Hunter